These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29808545)

  • 1. Insight into structural requirements of antiamoebic flavonoids: 3D-QSAR and G-QSAR studies.
    Fatima S; Gupta P; Agarwal SM
    Chem Biol Drug Des; 2018 Oct; 92(4):1743-1749. PubMed ID: 29808545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modelling studies for the discovery of new substituted pyridines derivatives with angiotensin II AT1 receptor antagonists.
    Sharma MC
    Interdiscip Sci; 2014 Sep; 6(3):197-207. PubMed ID: 25205497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Linear Quantitative Structure⁻Activity Relationships Modelling, Mechanistic Study and In-Silico Design of Flavonoids as Potent Antioxidants.
    Žuvela P; David J; Yang X; Huang D; Wong MW
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31083440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative QSAR studies of CYP1A2 inhibitor flavonoids using 2D and 3D descriptors.
    Roy K; Roy PP
    Chem Biol Drug Des; 2008 Nov; 72(5):370-82. PubMed ID: 19012573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A QSAR analysis of 2-phenoxy-N-substituted acetamide analogues as hypoxia-inducible factor-1(HIF-1) inhibitors: a rational approach to anticancer drug design.
    Noolvi MN; Patel HM; Kamboj S
    Med Chem; 2012 Jul; 8(4):599-614. PubMed ID: 22530909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Potent Antihypertensive Ligands Substituted Imidazolyl Biphenyl Sulfonylureas Analogs as Angiotensin II AT1 Receptor Antagonists by Molecular Modelling Studies.
    Sharma MC
    Interdiscip Sci; 2015 Sep; 7(3):221-32. PubMed ID: 26188391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling of some 1H-benzimidazole derivatives with biological activity against Entamoeba histolytica: a comparative molecular field analysis study.
    López-Vallejo F; Medina-Franco JL; Hernández-Campos A; Rodríguez-Morales S; Yépez L; Cedillo R; Castillo R
    Bioorg Med Chem; 2007 Jan; 15(2):1117-26. PubMed ID: 17074492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P56(lck) kinase inhibitor studies: a 3D QSAR approach towards designing new drugs from flavonoid derivatives.
    Gunda SK; Narasimha SK; Shaik M
    Int J Comput Biol Drug Des; 2014; 7(2-3):278-94. PubMed ID: 24878734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel semi-automated methodology for developing highly predictive QSAR models: application for development of QSAR models for insect repellent amides.
    Bhonsle JB; Bhattacharjee AK; Gupta RK
    J Mol Model; 2007 Jan; 13(1):179-208. PubMed ID: 17048015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems.
    Khlebnikov AI; Schepetkin IA; Domina NG; Kirpotina LN; Quinn MT
    Bioorg Med Chem; 2007 Feb; 15(4):1749-70. PubMed ID: 17166721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariate QSAR study on the antimutagenic activity of flavonoids against 3-NFA on Salmonella typhimurium TA98.
    Borges de Melo E; Ataide Martins JP; Marinho Jorge TC; Friozi MC; Castro Ferreira MM
    Eur J Med Chem; 2010 Oct; 45(10):4562-9. PubMed ID: 20696502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional quantitative structure-activity relationship (3D-QSAR) of 3-aryloxazolidin-2-one antibacterials.
    Karki RG; Kulkarni VM
    Bioorg Med Chem; 2001 Dec; 9(12):3153-60. PubMed ID: 11711290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4D-QSAR Molecular Modeling and Analysis of Flavonoid Derivatives as Acetylcholinesterase Inhibitors.
    Wang Y; Zhao Y; Wei C; Tian N; Yan H
    Biol Pharm Bull; 2021; 44(7):999-1006. PubMed ID: 34193695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring QSAR and pharmacophore mapping of structurally diverse selective matrix metalloproteinase-2 inhibitors.
    Halder AK; Saha A; Jha T
    J Pharm Pharmacol; 2013 Oct; 65(10):1541-54. PubMed ID: 24028622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling structural requirements of amino-pyrimidine T790M/L858R double mutant EGFR inhibitors: 2D and 3D QSAR study.
    Fatima S; Agarwal SM
    J Recept Signal Transduct Res; 2018 Aug; 38(4):299-306. PubMed ID: 30204041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2D and 3D QSAR models for identifying diphenylpyridylethanamine based inhibitors against cholesteryl ester transfer protein.
    Chen M; Yang X; Lai X; Gao Y
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4487-95. PubMed ID: 26346366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D-QSAR studies on fluroquinolones derivatives as inhibitors for tuberculosis.
    Bhattacharjee A; Mylliemngap BJ; Velmurugan D
    Bioinformation; 2012; 8(8):381-7. PubMed ID: 22570519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of potent antihypertensive ligands substituted imidazolyl biphenyl sulfonylureas analogs as angiotensin II AT
    Sharma MC
    Interdiscip Sci; 2014 Sep; ():. PubMed ID: 25183349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure based 3D-QSAR studies of Interleukin-2 inhibitors: Comparing the quality and predictivity of 3D-QSAR models obtained from different alignment methods and charge calculations.
    Halim SA; Zaheer-ul-Haq
    Chem Biol Interact; 2015 Aug; 238():9-24. PubMed ID: 26051521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.